Bale TA, Rosenblum MK (2022) The 2021 WHO Classification of Tumors of the Central Nervous System: an update on pediatric low-grade gliomas and glioneuronal tumors. Brain Pathol 32(4):e13060

Article  PubMed  PubMed Central  Google Scholar 

Benezech S, Saintigny P, Attignon V et al (2020) Tumor molecular profiling: pediatric results of the ProfiLER Study. JCO Precis Oncol 4:785–795

Article  PubMed  Google Scholar 

Berlanga P, Pierron G, Lacroix L et al (2022) The European MAPPYACTS Trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies. Cancer Discov 12(5):1266–1281

Article  PubMed  PubMed Central  Google Scholar 

Bielle F, Di Stefano AL, Meyronet D et al (2018) Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features. Brain Pathol 28(5):674–683

Article  CAS  PubMed  Google Scholar 

Broggi G, Piombino E, Altieri R et al (2022) Glioblastoma, IDH-wild type with FGFR3-TACC3 fusion: when morphology may reliably predict the molecular profile of a tumor. A case report and literature review. Front Neurol 13:823015

Article  PubMed  PubMed Central  Google Scholar 

Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555(7697):469–474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capper D, Stichel D, Sahm F et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136(2):181–210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castel D, Kergrohen T, Tauziède-Espariat A et al (2020) Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3–K27M mutation. Acta Neuropathol 139(6):1109–1113

Article  PubMed  Google Scholar 

Castel D, Philippe C, Kergrohen T et al (2018) Transcriptomic and epigenetic profiling of “diffuse midline gliomas, H3 K27M-mutant” discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Acta Neuropathol Commun 6(1):117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chatwin HV, Cruz Cruz J, Green AL (2021) Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy. Febs J 288(21):6127–6141

Article  CAS  PubMed  Google Scholar 

Clarke M, Mackay A, Ismer B et al (2020) Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov 10(7):942–963

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crowell C, Mata-Mbemba D, Bennett J et al (2022) Systematic review of diffuse hemispheric glioma, H3 G34-mutant: outcomes and associated clinical factors. Neurooncol Adv 4(1):vdac133

PubMed  PubMed Central  Google Scholar 

Di Stefano AL, Picca A, Saragoussi E et al (2020) Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions. Neuro Oncol 22(11):1614–1624

Article  PubMed  PubMed Central  Google Scholar 

Dor Y, Cedar H (2018) Principles of DNA methylation and their implications for biology and medicine. Lancet 392(10149):777–786

Article  CAS  PubMed  Google Scholar 

Ecker J, Selt F, Sturm D et al (2022) Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry. Eur J Cancer 180:71–84

Article  PubMed  Google Scholar 

Ferreyra Vega S, Olsson Bontell T, Corell A et al (2021) DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas. Clin Epigenet 13(1):102

Article  CAS  Google Scholar 

Ferreyra Vega S, Wenger A, Kling T et al (2022) Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas. Mod Pathol 35(11):1551–1561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedman GK, Johnston JM, Bag AK et al (2021) Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas. N Engl J Med 384(17):1613–1622

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gállego Pérez-Larraya J, Garcia-Moure M, Labiano S et al (2022) Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med 386(26):2471–2481

Article  PubMed  Google Scholar 

Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196(2):261–282

Article  CAS  PubMed  Google Scholar 

Gempt J, Withake F, Aftahy AK et al (2022) Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy. ESMO Open 7(5):100566

Article  CAS  PubMed  PubMed Central  Google Scholar 

GuerreiroStucklin AS, Ryall S, Fukuoka K et al (2019) Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun 10(1):4343

Article  Google Scholar 

Harttrampf AC, Lacroix L, Deloger M et al (2017) Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial. Clin Cancer Res 23(20):6101–6112

Article  CAS  PubMed  Google Scholar 

Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997–1003

Article  CAS  PubMed  Google Scholar 

Huse JT, Snuderl M, Jones DT et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133(3):417–429

Article  CAS  PubMed  Google Scholar 

Illingworth RS, Bird AP (2009) CpG islands—’a rough guide’. FEBS Lett 583(11):1713–1720

Article  CAS  PubMed  Google Scholar 

International Cancer Genome Consortium PedBrain Tumor P (2016) Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. Nat Med 22(11):1314–1320

Article  Google Scholar 

Jaunmuktane Z, Capper D, Jones DTW et al (2019) Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol Commun 7(1):24

Article  PubMed  PubMed Central  Google Scholar 

Johnson A, Severson E, Gay L et al (2017) Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist 22(12):1478–1490

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones C, Karajannis MA, Jones DT et al (2016) Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol

Kameda M, Otani Y, Ichikawa T et al (2017) Congenital glioblastoma with distinct clinical and molecular characteristics: case reports and a literature review. World Neurosurg 101:817

Article  Google Scholar 

Korshunov A, Capper D, Reuss D et al (2016) Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 131(1):137–146

Article  CAS  PubMed  Google Scholar 

Korshunov A, Schrimpf D, Ryzhova M et al (2017) H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol 134(3):507–516

Article  CAS  PubMed  Google Scholar 

Kurozumi K, Fujii K, Washio K et al (2022) Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion. Neurooncol Adv 4(1):vdac094

PubMed  PubMed Central  Google Scholar 

Kurozumi K, Nakano Y, Ishida J et al (2019) High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene. Brain Tumor Pathol 36(3):121–128

Article  CAS  PubMed  Google Scholar 

Lander ES, Linton LM, Birren B et al (2001) Initial sequencing and analysis of the human genome. Nature 409(6822):860–921

Article  CAS  PubMed  Google Scholar 

Li E, Zhang Y (2014) DNA methylation in mammals. Cold Spring Harb Perspect Biol 6(5):a019133

Article  PubMed  PubMed Central  Google Scholar 

Liu I, Jiang L, Samuelsson ER et al (2022) The landscape of tumor cell states and spatial organization in H3–K27M mutant diffuse midline glioma across age and location. Nat Genet 54(12):1881–1894

Article  CAS  PubMed  PubMed Central